|
Delayed
Nasdaq
05:40:28 18/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.2256 USD | -0.13% |
|
+12.24% | -80.80% |
| 17/07 | BioRestorative Therapies, Inc. Announces CEO Changes, Effective July 13, 2026 | CI |
| 17/07 | BioRestorative Therapies, Inc. Announces CFO Changes, Effective July 13, 2026 | CI |
Company Valuation: BioRestorative Therapies, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 15.16 | 10.1 | 8.19 | 9.895 | 10.43 | 5.756 | - | - |
| Change | - | -33.36% | -18.94% | 20.83% | 5.4% | -44.82% | - | - |
| Enterprise Value (EV) | 15.16 | 10.1 | 8.19 | 9.895 | 10.43 | 5.756 | 5.756 | 5.756 |
| Change | - | -33.36% | -18.94% | 20.83% | 5.4% | -44.82% | 0% | 0% |
| P/E | -0.12x | -0.54x | -0.51x | -1.23x | -0.74x | -0.46x | -0.56x | -0.55x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | 0x | 0x | -0x | 0x | 0x | -0.45x |
| Capitalization / Revenue | 330x | 84.3x | 56.2x | 24.7x | 29x | 4.1x | 2.49x | 1.84x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 4.1x | 2.49x | 1.84x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -0.42x | -0.37x | -0.32x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -37.3 | -5.11 | -3.42 | -1.16 | -1.58 | -0.495 | -0.405 | -0.41 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.046 | 0.1198 | 0.1458 | 0.401 | 0.3597 | 1.405 | 2.312 | 3.125 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -26.31 | -18.97 | -15.22 | -11.56 | -15.65 | -13.61 | -15.67 | -17.97 |
| Net income 1 | -44.3 | -18.49 | -14.42 | -8.979 | -14.24 | -13.52 | -15.56 | -17.83 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 4.3400 | 2.7500 | 1.7399 | 1.4300 | 1.1750 | 0.2259 | 0.2259 | 0.2259 |
| Nbr of stocks (in thousands) | 3,493 | 3,674 | 4,707 | 6,920 | 8,876 | 25,478 | - | - |
| Announcement Date | 30/3/22 | 27/3/23 | 1/4/24 | 28/3/25 | 26/3/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.46x | - | - | - | 5.76M | |
| 20.97x | 7.34x | 14.96x | 1.41% | 70.07B | |
| 30.34x | 7.64x | 23.38x | 0.05% | 52.87B | |
| -78.21x | 14.61x | -74.55x | -.--% | 27.02B | |
| 29.96x | 5.86x | 15.52x | -.--% | 23.61B | |
| -14.6x | 5.15x | -6.71x | -.--% | 23.38B | |
| 56.69x | 21.05x | 42.62x | 0.06% | 19.43B | |
| 25.59x | 4.85x | 16.27x | -.--% | 18.75B | |
| -802.92x | 37.67x | -14929.22x | -.--% | 15.85B | |
| 15.89x | 4.68x | 10.93x | -.--% | 12.7B | |
| Average | -71.67x | 12.09x | -1,654.09x | 0.17% | 26.37B | |
| Weighted average by Cap. | -36.48x | 10.35x | -890.98x | 0.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BRTX Stock
- Valuation BioRestorative Therapies, Inc.
Select your edition
All financial news and data tailored to specific country editions
